PGEN vs SPY Stock Comparison

SPY currently leads PGEN in this stock comparison, with AIQ scores of 63 vs 55. The clearest difference is risk resilience, while PGEN has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 8 points
PGEN
Healthcare
vs
SPY
Equity
PGEN
Precigen, Inc.
Price
$4.54
Day move
-2.58%
AIQ Score
55/100
Best edge
Value
Sector
Healthcare
SPY
State Street SPDR S&P 500 ETF
Leads
Price
$754
Day move
-0.36%
AIQ Score
63/100
Best edge
Risk Resilience
Sector
Equity

What is the main difference between PGEN and SPY?

SPY leads the current stock comparison as State Street SPDR S&P 500 ETF, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Precigen, Inc. vs State Street SPDR S&P 500 ETF

Data as of Nov 15, 2026· market close· PGEN (stock) vs SPY (ETF)· Coverage 65/66 fields· 42/42 directly comparable· Moderate confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

SPY leads

SPY leads by 8 AIQ points, primarily on Risk Resilience and Quality.

Competitive: 3 of 4 evidence groups support SPY, and its signal state is cleanly positive.

Evidence agreement: 3 of 4Comparison trend: Stable
PGEN

Precigen, Inc.

AIQ Score
55/100
AIQ Edge Score
5/10
SPY

State Street SPDR S&P 500 ETF

Leads
AIQ Score
63/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors SPY over PGEN, 63 versus 55 as of Nov 15, 2026. SPY's advantage is driven primarily by stronger risk resilience and quality, while PGEN holds the stronger value profile. SPY also shows the stronger technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor SPY today, and the comparison is rated Competitive on stability. SPY lead: Stable — the AIQ differential has held near 8 points over 30 sessions.

Compare Precigen, Inc. and State Street SPDR S&P 500 ETF across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

PGEN
+21.1%
SPY
+72.3%

Total return comparison

Growth of $10,000, distributions reinvested

PGEN $12,107 · SPY $17,232

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare PGEN and SPY against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

PGEN advantage
0
SPY advantage
  • Risk Resilience31 vs 72
    SPY +41
  • Value63 vs 37
    PGEN +26
  • Quality60 vs 79
    SPY +19
  • Momentum55 vs 59
    SPY +4

3 of 4 evidence groups favor SPY. SPY’s edge is concentrated in risk resilience and quality; PGEN keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

PGEN+1 AIQ

No factor moved materially.

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
SPY+1 AIQ

Largest factor move: Risk Resilience -1

No signal started or stopped since the prior session; its 5 active signals are unchanged.

SPY's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — PGEN and SPY both carry a full feed there.

The central trade-off

SPY (State Street SPDR S&P 500 ETF): the stronger current systematic profile, led by risk resilience and quality.

PGEN (Precigen, Inc.): the counter-case, on value, valuation — but at materially higher volatility, 127% against 22.1%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

SPY

SPY on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

Even

Growth figures are not covered for both names.

Value

PGEN

PGEN on the peer-relative Value factor, by 26 points.

Momentum

SPY

SPY on the Momentum factor, by 4 points.

Lower downside

SPY

SPY on Risk Resilience, by 41 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasurePGENSPYNote
Implied upside to target+164.3%—Level
Target dispersion0%—Lower is tighter analyst agreement
ConsensusBuy—Context, not a primary driver
Analysts covering4—Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 4 covered evidence groups favor SPY. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreSPY55 vs 63
FundamentalsNot coveredNot covered
ValuationPGENValue 63 vs 37
TechnicalsSPYPrice vs 50-day -32.6% vs -1.3%; vs 200-day -14% vs 3.1%
Risk ResilienceSPYRisk Resilience 31 vs 72
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PGEN and SPY and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is moderate at 8 points.
  • The leader's signal state is cleanly positive. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on SPY.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

SPY lead: Stable — the AIQ differential has held near 8 points over 30 sessions.

May 27PGEN leads above the line · SPY leads belowNov 13
Today
SPY +8
55 vs 63
7 sessions ago
SPY +3
62 vs 65
30 sessions ago
SPY +9
61 vs 70
90 sessions ago
SPY +7
58 vs 65

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

PGENConflicted

1 bullish / 2 bearish / 2 neutral, conflicted

Only PGEN

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (11.09%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
SPY

2 bullish / 0 bearish / 3 neutral

Only SPY

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • 52-Week High Proximity — bullish, risk_regime, long horizon (2.8%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • ATR Contraction - Coiling — neutral, volatility, short horizon (1.46%)

Both carry 1 more signal that do not separate them: Golden Cross Active.

PGEN is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

PGENDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.58%, AIQ +1 points).

SPYDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -0.36%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1PGEN closes the Risk Resilience gap — currently 41 points behind, the largest single contributor to SPY's edge.
  2. 2PGEN's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3SPY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricPGENSPY
Revenue growth (YoY)34.9%—
EPS growth (YoY)66.7%—
Gross margin91%—
Operating margin21.4%—
Return on equity (TTM)42.7%—
Debt to equity1.18—

Performance

SPY leads 4 of 6 windows
MetricPGENSPY
1 week (5 sessions)1.6%2.6%
1 month (20 sessions)-28.9%-1.2%
3 months (63 sessions)-30.7%-2.4%
6 months (126 sessions)2.7%2.1%
Year to date8.6%10.6%
1 year (252 sessions)12.9%10.4%

Technicals

SPY has the stronger structure
MetricPGENSPY
RSI (14)34.247.1
ADX (14)28.814.2
Price vs 50-day-32.6%-1.3%
Price vs 200-day-14%3.1%
Volatility (1M, annualized)127%22.1%

Risk

SPY is the more resilient
MetricPGENSPY
Beta1.621
Sharpe ratio0.570.63
Sortino ratio0.870.89
Max drawdown-50.7%-9.1%
Current drawdown-47%-3.2%
Annualized volatility85.4%13.6%
Value at risk (95%)-7.2%-1.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, PGEN or SPY?

On the Algovestiq AIQ Score, SPY is the stronger of the two as of Nov 15, 2026, scoring 63 against PGEN's 55. The edge comes from risk resilience and quality. PGEN is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is PGEN or SPY the better buy right now?

SPY carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 4 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor SPY over PGEN?

The composite weights Quality, Value, Momentum and Risk Resilience. SPY leads Risk Resilience by 41 points; PGEN leads Value by 26 points; SPY leads Quality by 19 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, PGEN or SPY?

Analyst price targets imply +164.3% upside for PGEN and not covered for SPY. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, PGEN or SPY?

PGEN is the better-valued of the two on the peer-relative Value factor. PGEN on the peer-relative Value factor, by 26 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, PGEN or SPY?

Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, PGEN or SPY?

SPY on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, PGEN or SPY?

SPY is the more resilient of the two, so the other name carries the higher downside risk. SPY on Risk Resilience, by 41 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is PGEN more profitable than SPY?

Margin data is not comparable for both names in the current snapshot.

Is SPY's lead over PGEN getting stronger or weaker?

SPY lead: Stable — the AIQ differential has held near 8 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the PGEN vs SPY verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: PGEN closes the Risk Resilience gap — currently 41 points behind, the largest single contributor to SPY's edge; PGEN's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; SPY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about PGEN and SPY?

PGEN: 1 bullish / 2 bearish / 2 neutral, conflicted. SPY: 2 bullish / 0 bearish / 3 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PGEN is Golden Cross Active (bullish, long horizon). On SPY it is Golden Cross Active (bullish, long horizon).

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.